A Review on Pharmacovigilance: Current Trends and Future Directions

Pharmacovigilance plays a vital role in ensuring the safety and efficacy of medications. This review provides an overview of current trends and future directions in pharmacovigilance, highlighting advancements in signal detection, risk management, and minimization strategies. The article discusses the increasing importance of real-world evidence, artificial intelligence, and machine learning in pharmacovigilance. Regulatory updates, including the implementation of the European Medicines Agency's (EMA) Good Pharmacovigilance Practices and the US Food and Drug Administration's (FDA) Safety Information and Adverse Event Reporting regulations, are also examined. Furthermore, this review explores emerging challenges and opportunities in pharmacovigilance, such as: - The growing need for personalized medicine safety monitoring - The integration of pharmacogenomics and precision medicine - The impact of social media and digital health technologies on adverse event reporting - The evolving role of patients and healthcare professionals in pharmacovigilance.

Publication Details

Journal
Zenodo (CERN European Organization for Nuclear Research)
Published
2024-11-18
DOI
https://doi.org/10.5281/zenodo.14178067
Primary Topic
Pharmacovigilance and Adverse Drug Reactions
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

A Review on Pharmacovigilance: Current Trends and Future Directions

Zenodo (CERN European Organization for Nuclear Research)
Pharmacovigilance and Adverse Drug Reactions
article

A Review on Pharmacovigilance: Current Trends and Future Directions

article en

Abstract

Pharmacovigilance plays a vital role in ensuring the safety and efficacy of medications. This review provides an overview of current trends and future directions in pharmacovigilance, highlighting advancements in signal detection, risk management, and minimization strategies. The article discusses the increasing importance of real-world evidence, artificial intelligence, and machine learning in pharmacovigilance. Regulatory updates, including the implementation of the European Medicines Agency's (EMA) Good Pharmacovigilance Practices and the US Food and Drug Administration's (FDA) Safety Information and Adverse Event Reporting regulations, are also examined. Furthermore, this review explores emerging challenges and opportunities in pharmacovigilance, such as: - The growing need for personalized medicine safety monitoring - The integration of pharmacogenomics and precision medicine - The impact of social media and digital health technologies on adverse event reporting - The evolving role of patients and healthcare professionals in pharmacovigilance.

Zenodo (CERN European Organization for Nuclear Research)
Openalex Percentile: Top 55%
Pharmacovigilance and Adverse Drug Reactions
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

A Review on Pharmacovigilance: Current Trends and Future Directions · Zenodo (CERN European Organization for Nuclear Research) (2024) | TGRS Research Map | TGRS